Publications by authors named "Dominik Heimann"

Claim this Profile
A
A novel class of oligoarylamide antibiotics defined by albicidins and cystobactamids.
Marcel Kulike-Koczula, Dominik Heimann, Tobias Eulberg, Daniel Kohnhäuser, Roderich D Süssmuth

Nat Prod Rep· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibacterials with Novel Chemical Scaffolds in Clinical Development.
Dominik Heimann, Daniel Kohnhäuser, Alexandra Jana Kohnhäuser, Mark Brönstrup

Drugs· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
YgiV promoter mutations cause resistance to cystobactamids and reduced virulence factor expression in Escherichia coli.
Timo Risch, Dominik Kolling, Dietrich Mostert, Tim Seedorf, Dominik Heimann

NPJ Antimicrob Resist· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of the Central α-Amino Acid in Cystobactamids to the Broad-Spectrum, Resistance-Breaking Antibiotic CN-CC-861.
Daniel Kohnhäuser, Tim Seedorf, Katarina Cirnski, Dominik Heimann, Janetta Coetzee

J Med Chem· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A MassQL-Integrated Molecular Networking Approach for the Discovery and Substructure Annotation of Bioactive Cyclic Peptides.
Tim Berger, Judith Alenfelder, Sophie Steinmüller, Dominik Heimann, Namrata Gohain

J Nat Prod· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Total synthesis and mechanism of action of the antibiotic armeniaspirol A.
Nanaji Arisetti, Hazel L S Fuchs, Janetta Coetzee, Manuel Orozco, Dominik Ruppelt, Dominik Heimann

Chem Sci· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological Activation of Non-canonical NF-κB Signaling Activates Latent HIV-1 Reservoirs .
Lars Pache, Matthew D Marsden, Peter Teriete, Alex J Portillo, Dominik Heimann

Cell Rep Med· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of the metabolic stability of a fluorinated cannabinoid receptor subtype 2 (CB) ligand designed for PET studies.
Dominik Heimann, Frederik Börgel, Henk de Vries, Marius Patberg, Eliot Jan-Smith

Eur J Med Chem· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of pharmacokinetic properties by modification of a carbazole-based cannabinoid receptor subtype 2 (CB) ligand.
Dominik Heimann, Frederik Börgel, Henk de Vries, Kim Bachmann, Victoria E Rose

Eur J Med Chem· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioisosteric replacement of central 1,2,4-oxadiazole ring of high affinity CB ligands by regioisomeric 1,3,4-oxadiazole ring.
Dominik Heimann, Corinna Lueg, Henk de Vries, Bastian Frehland, Dirk Schepmann

Medchemcomm· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis